These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9400017)

  • 1. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
    Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of N-methyl-D-aspartate-evoked currents in rat cortical cultures by ARL 15896AR.
    Mealing GA; Lanthorn TH; Small DL; Black MA; Laferriere NB; Morley P
    J Pharmacol Exp Ther; 1997 Apr; 281(1):376-83. PubMed ID: 9103520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties.
    Palmer GC; Murray RJ; Cramer CL; Stagnitto ML; Knowles MK; Freedman LR; Eismann MS; Mahmood N; Balestra M; Borrelli AR; Hudzik TJ; McCarthy DJ
    J Pharmacol Exp Ther; 1999 Jan; 288(1):121-32. PubMed ID: 9862762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.
    Bordi F; Pietra C; Ziviani L; Reggiani A
    Exp Neurol; 1997 Jun; 145(2 Pt 1):425-33. PubMed ID: 9217078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
    Tortella FC; Britton P; Williams A; Lu XC; Newman AH
    J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remacemide hydrochloride and ARL 15896AR lack abuse potential: additional differences from other uncompetitive NMDA antagonists.
    Hudzik TJ; Freedman L; Palmer GC
    Epilepsia; 1996 Jun; 37(6):544-50. PubMed ID: 8641231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroprotective effects of N1-dansyl-spermine in the gerbil model of cerebral ischaemia.
    Kirby BP; Shaw GG
    Brain Res; 2004 Jun; 1011(1):74-83. PubMed ID: 15140646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils.
    Gigler G; Szénási G; Simó A; Lévay G; Hársing LG; Sas K; Vécsei L; Toldi J
    Eur J Pharmacol; 2007 Jun; 564(1-3):116-22. PubMed ID: 17407777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of a novel herbal decoction on focal cerebral ischemia in a rodent model.
    Kim MG; Choi JH; Lim JP; Kim DK; Shin TY; Boo Y; Kim SY; Kim H; Ha E; Park HK; Kim J; Lim HS; Kim EH; Kim JB; Leem KH
    Neurol Res; 2007; 29 Suppl 1():S16-22. PubMed ID: 17359635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARR 15896 AR. ARL 15896, ARL 15896AR, ARR 15896, FPL 15896, FPL 15896AR.
    Drugs R D; 1999 Jan; 1(1):14-5. PubMed ID: 10565970
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats.
    Block F; Schmitt W; Schwarz M
    J Neurol Sci; 1996 Aug; 139(2):167-72. PubMed ID: 8856648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH; Chen J; Lan JQ; Simon RP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide scavenger carboxy-PTIO reduces infarct volume following permanent focal ischemia.
    Fang SY; Tseng CC; Yang YL; Lee EJ; Chen HY; Bhardwaj A; Chen TY
    Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):141-6. PubMed ID: 17037001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
    Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
    Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.